Efficacy and Safety of Mirodenafil Oro-Dispersible Film in Korean Patients with Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Phase IV Studyopen access
- Authors
- Lee, Sung Won; Son, Hwancheol; Lee, Seung Wook; Cho, Kang Su; Moon, Du Geon; Yang, Dae Yul; Chung, Woo Sik; Suh, Jun-Kyu; Park, Hyun Jun; Min, Kweonsik; Moon, Ki Hak; Park, Kwangsung; Park, Jong Kwan; Hyun, Jae Seog; Yang, Sang-Kuk
- Issue Date
- Apr-2022
- Publisher
- 대한남성과학회
- Keywords
- Erectile dysfunction; Mirodenafil; Orally disintegrating formulations; Oro-dispersible film; Phosphodiesterase 5 inhibitors
- Citation
- The World Journal of Men's Health, v.40, no.2, pp.280 - 289
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- The World Journal of Men's Health
- Volume
- 40
- Number
- 2
- Start Page
- 280
- End Page
- 289
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190517
- DOI
- 10.5534/wjmh.200157
- ISSN
- 2287-4208
- Abstract
- Purpose: To investigate the efficacy, safety, and tolerability of oro-dispersible film (ODF) formulation of mirodenafil 50 mg and 100 mg for the treatment of patients with erectile dysfunction (ED) in Korea.
Materials and Methods:Materials and Methods: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 129 subjects was per-formed. Subjects were randomized to either placebo or mirodenafil ODF 50 mg or 100 mg to be taken in an “on demand” manner for 8 weeks. The primary efficacy variable was the International Index of Erectile Dysfunction (IIEF)-5 questionnaire. The secondary efficacy variables comprised Sexual Encounter Profile questions 2 and 3 (SEP2 and SEP3), the Global Assessment Question (GAQ), and the Life Satisfaction Checklist (LSC).
Results:Results: IIEF-5 was significantly increased in all groups after treatment. However, compared to the placebo group, only the mirode-nafil ODF 100 mg group showed a significant difference. SEP2 and SEP3 were increased in both mirodenafil groups; however, the increase was not statistically significant for SEP2. In terms of GAQ and LSC, the mirodenafil ODF groups showed significant increases compared with the baseline. Most treatment-associated adverse events were mild and resolved spontaneously.
Conclusions:Conclusions: Mirodenafil ODF is an effective and well-tolerated agent for the treatment of patients with ED in Korea.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 비뇨의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/190517)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.